Blog
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates
Agenus (AGEN) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $1.61. This compares to loss of $3.04 per share a year ago. These figures are
How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW
For Immediate Release
Chicago, IL – May 12, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the
Jack in the Box to Post Q2 Earnings: What's in Store for the Stock?
Jack in the Box JACK is scheduled to report second-quarter fiscal 2025 results on May 14, after the closing bell. In the previous quarter, the company’s earnings surpassed the Zacks Consensus
How Should an Investor Play LUNR Stock Pre-Q1 Earnings Release?
Intuitive Machines, Inc. LUNR is slated to report first-quarter 2025 results on May 13, before market open.The Zacks Consensus Estimate for first-quarter revenues is pegged at $59.4 million
Cenovus Energy Q1 Earnings Beat on Higher Upstream Production
Cenovus Energy Inc. CVE reported first-quarter 2025 adjusted earnings per share of 32 cents, which beat the Zacks Consensus Estimate of 29 cents. The bottom line, however, declined from the year-ago
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago. These
3 Stocks With Upgraded Broker Ratings to Navigate Market Uncertainties
Stock markets have been experiencing significant volatility of late. This is largely because of the ongoing tariff war, which has also led to expectations of economic slowdown and rising inflation
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?
Women’s health device maker, Hologic HOLX, slashed its earnings forecast for the full fiscal 2025, even as the latest second-quarter results topped expectations. The revenue target of $4.05-$4.10
SelectQuote (SLQT) Misses Q3 Earnings and Revenue Estimates
SelectQuote (SLQT) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago. These
Chegg (CHGG) Reports Q1 Loss, Tops Revenue Estimates
Chegg (CHGG) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.26 per share a year ago. These figures are
HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up
Haemonetics Corporation HAE delivered fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.24, which rose 37.8% year over year. The bottom line topped the Zacks Consensus Estimate by
ProAssurance Q1 Earnings Miss Estimates on Declining Premiums
Shares of ProAssurance Corporation PRA have remained relatively stable, falling only 0.3% since the company reported first-quarter 2025 results on May 6. The weaker-than-expected quarterly results
Advantage Solutions Inc. (ADV) Reports Q1 Loss, Misses Revenue Estimates
Advantage Solutions Inc. (ADV) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.16 per share a year ago. These figures are
Is the Options Market Predicting a Spike in Texas Instruments Stock?
Investors in Texas Instruments Incorporated TXN need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $85 Call had some of the
Here's How Much You'd Have If You Invested $1000 in Broadcom Inc. a Decade Ago
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
Here's How Much a $1000 Investment in Leidos Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
If You Invested $1000 in Netflix a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Are Options Traders Betting on a Big Move in TripAdvisor Stock?
Investors in Tripadvisor, Inc TRIP need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $8 Call had some of the highest implied
NRG Energy (NRG) Beats Q1 Earnings and Revenue Estimates
NRG Energy (NRG) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $1.80 per share. This compares to earnings of $0.80 per share a year ago. These figures
Macerich (MAC) Q1 FFO and Revenues Top Estimates
Macerich (MAC) came out with quarterly funds from operations (FFO) of $0.33 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to FFO of $0.31 per share a year ago
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates
Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.35 per share a year ago. These
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $1.50 per share versus the Zacks Consensus Estimate of a loss of $2.72. This compares to loss of $13.92 per share a year ago




